226 related articles for article (PubMed ID: 25027688)
1. Lymphopenia is an independent predictor of inferior outcome in papillary renal cell carcinoma.
Mehrazin R; Uzzo RG; Kutikov A; Ruth K; Tomaszewski JJ; Dulaimi E; Ginzburg S; Abbosh PH; Ito T; Corcoran AT; Chen DY; Smaldone MC; Al-Saleem T
Urol Oncol; 2015 Sep; 33(9):388.e19-25. PubMed ID: 25027688
[TBL] [Abstract][Full Text] [Related]
2. Lymphopenia is an independent predictor of inferior outcome in clear cell renal carcinoma.
Saroha S; Uzzo RG; Plimack ER; Ruth K; Al-Saleem T
J Urol; 2013 Feb; 189(2):454-61. PubMed ID: 23041457
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of preoperative neutrophil-to-lymphocyte ratio in papillary renal cell carcinoma patients after receiving curative surgery based on a retrospective cohort.
Zhang Z; Yu Y; Zheng J; Zhang M; Niu H
BMC Urol; 2021 Mar; 21(1):43. PubMed ID: 33752642
[TBL] [Abstract][Full Text] [Related]
4. Low preoperative lymphocyte-monocyte ratio (LMR) represents a potentially poor prognostic factor in nonmetastatic clear cell renal cell carcinoma.
Hutterer GC; Stoeckigt C; Stojakovic T; Jesche J; Eberhard K; Pummer K; Zigeuner R; Pichler M
Urol Oncol; 2014 Oct; 32(7):1041-8. PubMed ID: 25027686
[TBL] [Abstract][Full Text] [Related]
5. Type II papillary histology predicts poor outcome in patients with renal cell carcinoma and vena cava thrombus.
Kim KH; You D; Jeong IG; Kwon TW; Cho YM; Hong JH; Ahn H; Kim CS
BJU Int; 2012 Dec; 110(11 Pt B):E673-8. PubMed ID: 22973869
[TBL] [Abstract][Full Text] [Related]
6. An epidemiological and clinicopathological study of type 1 vs. type 2 morphological subtypes of papillary renal cell carcinoma- results from a nation-wide study covering 50 years in Iceland.
Runarsson TG; Bergmann A; Erlingsdottir G; Petursdottir V; Heitmann LA; Johannesson A; Asbjornsson V; Axelsson T; Hilmarsson R; Gudbjartsson T
BMC Urol; 2024 May; 24(1):105. PubMed ID: 38741053
[TBL] [Abstract][Full Text] [Related]
7. Papillary (chromophil) renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 62 cases.
Amin MB; Corless CL; Renshaw AA; Tickoo SK; Kubus J; Schultz DS
Am J Surg Pathol; 1997 Jun; 21(6):621-35. PubMed ID: 9199639
[TBL] [Abstract][Full Text] [Related]
8. Histologic subtype needs to be considered after partial nephrectomy in patients with pathologic T1a renal cell carcinoma: papillary vs. clear cell renal cell carcinoma.
Yoo S; You D; Jeong IG; Song C; Hong B; Hong JH; Ahn H; Kim CS
J Cancer Res Clin Oncol; 2017 Sep; 143(9):1845-1851. PubMed ID: 28451753
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological and survival analysis of clinically advanced papillary and chromophobe renal cell carcinoma.
Kaldany A; Paulucci DJ; Kannappan M; Beksac AT; Anastos H; Okhawere K; Sfakianos JP; Badani KK
Urol Oncol; 2019 Oct; 37(10):727-734. PubMed ID: 31174958
[TBL] [Abstract][Full Text] [Related]
10. The Prognostic Value of Treatment-Related Lymphopenia in Nasopharyngeal Carcinoma Patients.
Liu LT; Chen QY; Tang LQ; Guo SS; Guo L; Mo HY; Chen MY; Zhao C; Guo X; Qian CN; Zeng MS; Bei JX; Tan J; Chen S; Hong MH; Shao JY; Sun Y; Ma J; Mai HQ
Cancer Res Treat; 2018 Jan; 50(1):19-29. PubMed ID: 28392551
[TBL] [Abstract][Full Text] [Related]
11. Clinically localized type 1 and 2 papillary renal cell carcinomas have similar survival outcomes following surgery.
Ledezma RA; Negron E; Paner GP; Rjepaj C; Lascano D; Haseebuddin M; Dangle P; Shalhav AL; Crist H; Raman JD; Joel DeCastro G; Harik L; Paroder M; Uzzo RG; Kutikov A; Eggener SE
World J Urol; 2016 May; 34(5):687-93. PubMed ID: 26407582
[TBL] [Abstract][Full Text] [Related]
12. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
[TBL] [Abstract][Full Text] [Related]
13. Preoperative Anemia as an Independent Prognostic Indicator of Papillary Renal Cell Carcinoma.
Huang J; Feldman AS; Dong L; Cornejo K; Liu Q; Dahl DM; Wu S; Blute ML; Huang Y; Wu CL
Clin Genitourin Cancer; 2015 Oct; 13(5):e353-60. PubMed ID: 25998556
[TBL] [Abstract][Full Text] [Related]
14. Morphological subtyping of papillary renal cell carcinoma: clinicopathological characteristics and prognosis.
Yamashita S; Ioritani N; Oikawa K; Aizawa M; Endoh M; Arai Y
Int J Urol; 2007 Aug; 14(8):679-83. PubMed ID: 17681054
[TBL] [Abstract][Full Text] [Related]
15. [Incidence and long-term prognosis of papillary renal cancer. Results of a retrospective multicenter study].
Waalkes S; Roos FC; Eggers H; Schumacher S; Janssen M; Wegener G; Thüroff JW; Hofmann R; Schrader M; Kuczyk MA; Schrader AJ;
Urologe A; 2011 Sep; 50(9):1125-9. PubMed ID: 21845424
[TBL] [Abstract][Full Text] [Related]
16. Prognostic indicators for renal cell carcinoma: a multivariate analysis of 643 patients using the revised 1997 TNM staging criteria.
Tsui KH; Shvarts O; Smith RB; Figlin RA; deKernion JB; Belldegrun A
J Urol; 2000 Apr; 163(4):1090-5; quiz 1295. PubMed ID: 10737472
[TBL] [Abstract][Full Text] [Related]
17. Papillary renal cell carcinoma: correlation of tumor grade and histologic characteristics with clinical outcome.
Cornejo KM; Dong F; Zhou AG; Wu CL; Young RH; Braaten K; Sadow PM; Nielsen GP; Oliva E
Hum Pathol; 2015 Oct; 46(10):1411-7. PubMed ID: 26297250
[TBL] [Abstract][Full Text] [Related]
18. Radiation-related lymphopenia as a new prognostic factor in limited-stage small cell lung cancer.
Cho O; Oh YT; Chun M; Noh OK; Lee HW
Tumour Biol; 2016 Jan; 37(1):971-8. PubMed ID: 26264618
[TBL] [Abstract][Full Text] [Related]
19. Effect of hypertension on preoperative neutrophil-lymphocyte ratio evaluation of prognosis of renal cell carcinoma.
Sun J; Ning H; Sun J; Qu X
Urol Oncol; 2016 May; 34(5):239.e9-15. PubMed ID: 26803433
[TBL] [Abstract][Full Text] [Related]
20. Prognostic and discriminative power of the 7th TNM classification for patients with surgically treated papillary renal cell carcinoma: results of a multi-institutional validation study (CORONA subtype project).
May M; Surcel C; Capitanio U; Dell'Oglio P; Klatte T; Shariat S; Ecke T; Wolff I; Vergho D; Wagener N; Huck N; Pahernik S; Zastrow S; Wirth M; Borgmann H; Haferkamp A; Musquera M; Krabbe LM; Herrmann E; Scavuzzo A; Mirvald C; Hutterer G; Zigeuner R; Stief CG; Waidelich R; Cindolo L; Kalusova K; Brookman-May SD;
Scand J Urol; 2017 Aug; 51(4):269-276. PubMed ID: 28399699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
